Literature DB >> 18382789

Gene expression profiling in women with breast cancer in a Saudi population.

Suad M Bin Amer1, Zakia Maqbool, Maimoona S Nirmal, Amal T Qattan, Syed S Hussain, Hatim A Jeprel, Asma M Tulbah, Osama A Malik, Taher A Al-Tweigeri.   

Abstract

OBJECTIVE: To generate consensus gene expression profiles of invasive breast tumors from a small cohort of Saudi females, and to explore the possibility that they may be broadly conserved between Caucasian and Middle Eastern populations.
METHODS: This study was performed at King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia, from January 2005 to January 2007. Gene expression profiles were generated from 38 invasive breast tumors, and 8 tumor adjacent tissues TATs using BD Atlas cDNA expression arrays containing 1176 genes. Results were confirmed by reverse transcriptase polymerase chain reaction, and analyzed by 2-dimensional unsupervised hierarchical clustering.
RESULTS: The analysis identified 48 differentially expressed genes in tumors from which 25 are already reported by various western studies. Forty-three of these genes were also differentially expressed in TATs. The same data set has been able to distinguish between tumors and the TATs, interestingly by using only 4 of the differentially expressed genes. Moreover, we were able to group the patients according to prognosis to an extent by hierarchical clustering.
CONCLUSION: Our results indicate that expression profiles between Saudi females with breast cancer and the Caucasian population are conserved to some extent, and can be used to classify patients according to prognostic groups. We also suggest 3 differentially-expressed genes IGHG3, CDK6, and RPS9 in tumors may have a novel role in breast cancer. In addition, the role of TATs is much more essential in breast cancer, and needs to be explored thoroughly.

Entities:  

Mesh:

Year:  2008        PMID: 18382789

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  7 in total

1.  Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients.

Authors:  Mohamed A Shawarby; Dalal M Al-Tamimi; Ayesha Ahmed
Journal:  Diagn Pathol       Date:  2011-06-24       Impact factor: 2.644

2.  Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.

Authors:  Tarique N Hasan; B Leena Grace; Gowhar Shafi; Rabbani Syed
Journal:  Clin Transl Oncol       Date:  2012-12-21       Impact factor: 3.405

3.  Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients.

Authors:  Ali A Alshatwi; Gowhar Shafi; Tarique N Hasan; Naveed Ahmed Syed; Amal A Al-Hazzani; Mohammed A Alsaif; Abdulaziz A Alsaif
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

4.  Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.

Authors:  Chi Zhang; Jing-Hui Zheng; Zong-Han Lin; Hao-Yuan Lv; Zhuo-Miao Ye; Yue-Ping Chen; Xiao-Yun Zhang
Journal:  Aging (Albany NY)       Date:  2020-02-09       Impact factor: 5.682

5.  Identification of the Antigens Recognised by Colorectal Cancer Patients Using Sera from Patients Who Exhibit a Crohn's-like Lymphoid Reaction.

Authors:  Viktoriya B Boncheva; Michael Linnebacher; Said Kdimati; Hannah Draper; Laurence Orchard; Ken I Mills; Gerald O'Sullivan; Mark Tangney; Barbara-Ann Guinn
Journal:  Biomolecules       Date:  2022-07-29

6.  Identification of novel autoantibodies for detection of malignant mesothelioma.

Authors:  Xufei Zhang; Weike Shen; Xiaomin Dong; Jiangping Fan; Lixia Liu; Xu Gao; Kemp H Kernstine; Li Zhong
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

7.  Global identification of genes and pathways regulated by Akt during activation of T helper cells.

Authors:  Jing Cheng; Lawrence P Kane
Journal:  F1000Res       Date:  2013-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.